138 related articles for article (PubMed ID: 17205866)
1. Survival time of AIDS patients in Bamrasnaradura Institute.
Chaovavanich A; Chottanapund S; Ausavapipit J; Adulyawat N; Ubonsai W
J Med Assoc Thai; 2006 Nov; 89(11):1859-63. PubMed ID: 17205866
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
3. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
4. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
[TBL] [Abstract][Full Text] [Related]
5. [Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
Moreno Ruiz O; Ferrer Novella E; Torrón Fernández C; Arazo Garcés P; Melcon Sánchez B; Honrubia López FM
Arch Soc Esp Oftalmol; 2001 Jul; 76(7):397-402. PubMed ID: 11438875
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.
Kiertiburanakul S; Khongnorasat S; Rattanasiri S; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):237-43. PubMed ID: 17375626
[TBL] [Abstract][Full Text] [Related]
7. The impact of antiretroviral therapy on AIDS and survival.
Lundgren JD; Mocroft A
J HIV Ther; 2006 Jun; 11(2):36-8. PubMed ID: 16981594
[No Abstract] [Full Text] [Related]
8. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients.
Manosuthi W; Kiertiburanakul S; Chaovavanich A; Sungkanuparph S
J Med Assoc Thai; 2007 Feb; 90(2):244-50. PubMed ID: 17375627
[TBL] [Abstract][Full Text] [Related]
9. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.
Rajendran PM; Dolev JC; Heaphy MR; Maurer T
Arch Dermatol; 2005 Oct; 141(10):1227-31. PubMed ID: 16230559
[TBL] [Abstract][Full Text] [Related]
10. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
11. Maintaining antiretroviral therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and profound immunodeficiency.
Kousignian I; Abgrall S; Grabar S; Mahamat A; Teicher E; Rouveix E; Costagliola D;
Clin Infect Dis; 2008 Jan; 46(2):296-304. PubMed ID: 18171266
[TBL] [Abstract][Full Text] [Related]
12. [Survival of patients with AIDS treated with protease inhibitors].
Martínez Avilés P; Berbegal Serra J; López Benito I
An Med Interna; 1999 May; 16(5):225-8. PubMed ID: 10389306
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
14. Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.
Mocroft A; Ledergerber B; Zilmer K; Kirk O; Hirschel B; Viard JP; Reiss P; Francioli P; Lazzarin A; Machala L; Phillips AN; Lundgren JD;
AIDS; 2007 Sep; 21(14):1867-75. PubMed ID: 17721094
[TBL] [Abstract][Full Text] [Related]
15. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy.
Bertschy S; Opravil M; Cavassini M; Bernasconi E; Schiffer V; Schmid P; Flepp M; Chave JP; Christen A; Furrer H;
Clin Microbiol Infect; 2006 Jul; 12(7):666-71. PubMed ID: 16774564
[TBL] [Abstract][Full Text] [Related]
16. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
Cozzi-Lepri A; Phillips AN; Ruiz L; Clotet B; Loveday C; Kjaer J; Mens H; Clumeck N; Viksna L; Antunes F; Machala L; Lundgren JD;
AIDS; 2007 Mar; 21(6):721-32. PubMed ID: 17413693
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
[TBL] [Abstract][Full Text] [Related]
19. [New AIDS study confirms: triple combination therapy with the protease inhibitor indinavir lowers the risk of mortality by 50%].
Praxis (Bern 1994); 1997 May; 86(20):860. PubMed ID: 9312815
[No Abstract] [Full Text] [Related]
20. What's new in the fight against AIDS.
Godwin C
RN; 2004 Apr; 67(4):46-52; quiz 53. PubMed ID: 15132046
[No Abstract] [Full Text] [Related]
[Next] [New Search]
